Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland - a qualitative study
Abstract Background Fingolimod is an oral multiple sclerosis drug that is considered a specialty drug due to its high cost and safety issues. The Fingolimod Patient Support Program (F-PSP) is a specialty pharmacy service developed to ensure the responsible use of fingolimod by promoting patient safe...
Saved in:
Main Authors: | Aline Bourdin (Author), Julie Dubois (Author), Rose-Anna Foley (Author), Myriam Schluep (Author), Olivier Bugnon (Author), Jérôme Berger (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland
by: Claudine Leuthold, et al.
Published: (2018) -
Vision and practice of self-care for community pharmacy in Switzerland
by: Noelia Amador-Fernández, et al.
Published: (2023) -
The effect of Fingolimod on patients with moderate to severe COVID‐19
by: Soheil Teymouri, et al.
Published: (2023) -
Safety of generic fingolimod
by: O. M. Koval, et al.
Published: (2018) -
Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results
by: Mélanie Lelubre, et al.
Published: (2018)